uniQure (QURE)
(Delayed Data from NSDQ)
$61.56 USD
-2.10 (-3.29%)
Updated Oct 10, 2025 03:59 PM ET
After-Market: $60.06 -1.50 (-2.43%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, uniQure N.V. has a market cap of $3.49B, which represents its share price of $63.65 multiplied by its outstanding shares number of 54.87M. As a mid-cap company, QURE's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
QURE 61.56 -2.10(-3.29%)
Will QURE be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for QURE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QURE
QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study
Strength Seen in uniQure (QURE): Can Its 247.7% Jump Turn into More Strength?
QURE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think uniQure (QURE) Could Surge 142.67%: Read This Before Placing a Bet
uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates
3 Top Genomics Stocks to Add to Your Portfolio in 2025
Other News for QURE
Is QURE likely to continue higher? Slingshot Bullish shows up after sliding 3.29%
QURE makes New 52 Week Closing High on October 9
New 52 Week Closing High appears for QURE after 3.54% move
Making Money In Biotech Stocks
RBC Capital Sticks to Their Buy Rating for uniQure (QURE)